Back to User profile » Dr Xingmei Duan

Papers published by Dr Xingmei Duan:


Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles

Huang J, Wang K, Fu X, Zhu M, Chen X, Gao Y, Ma P, Duan X, Men K

International Journal of Nanomedicine 2023, 18:8059-8075

Published Date: 28 December 2023

Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity

Li J, Zhang J, Gao Y, Lei S, Wu J, Chen X, Wang K, Duan X, Men K

International Journal of Nanomedicine 2023, 18:5961-5982

Published Date: 24 October 2023

Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy

Ma P, Li J, Gao Y, Wu J, Men K, Li C, Men Y, Duan X

International Journal of Nanomedicine 2022, 17:2925-2941

Published Date: 4 July 2022

Multifunctional Gold Nanoparticles in Cancer Diagnosis and Treatment

Yang Y, Zheng X, Chen L, Gong X, Yang H, Duan X, Zhu Y

International Journal of Nanomedicine 2022, 17:2041-2067

Published Date: 6 May 2022

Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy

Gao Y, Men K, Pan C, Li J, Wu J, Chen X, Lei S, Gao X, Duan X

International Journal of Nanomedicine 2021, 16:5211-5232

Published Date: 30 July 2021

Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA

Zhang H, Men K, Pan C, Gao Y, Li J, Lei S, Zhu G, Li R, Wei Y, Duan X

International Journal of Nanomedicine 2020, 15:9875-9890

Published Date: 7 December 2020

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

Zhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, Tong R, Zhong L

Drug Design, Development and Therapy 2019, 13:4321-4330

Published Date: 19 December 2019

Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy

Zhang X, Men K, Zhang Y, Zhang R, Yang L, Duan X

International Journal of Nanomedicine 2019, 14:2733-2751

Published Date: 23 April 2019

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J

International Journal of Nanomedicine 2018, 13:1443-1456

Published Date: 9 March 2018

Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis

Zhou L, Duan X, Zeng S, Men K, Zhang X, Yang L, Li X

International Journal of Nanomedicine 2015, 10:5205-5218

Published Date: 18 August 2015